Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Traenka, Christopher"'
Autor:
Zietz, Annaelle, Polymeris, Alexandros A, Helfenstein, Fabrice, Schaedelin, Sabine, Hert, Lisa, Wagner, Benjamin, Seiffge, David J, Traenka, Christopher, Altersberger, Valerian L, Dittrich, Tolga, Kaufmann, Josefin, Ravanelli, Flavia, Fladt, Joachim, Fisch, Urs, Thilemann, Sebastian, De Marchis, Gian Marco, Gensicke, Henrik, Bonati, Leo H, Katan, Mira, Fischer, Urs, Lyrer, Philippe, Engelter, Stefan T, Peters, Nils
Publikováno v:
Zietz, Annaelle; Polymeris, Alexandros A; Helfenstein, Fabrice; Schaedelin, Sabine; Hert, Lisa; Wagner, Benjamin; Seiffge, David J; Traenka, Christopher; Altersberger, Valerian L; Dittrich, Tolga; Kaufmann, Josefin; Ravanelli, Flavia; Fladt, Joachim; Fisch, Urs; Thilemann, Sebastian; De Marchis, Gian Marco; Gensicke, Henrik; Bonati, Leo H; Katan, Mira; Fischer, Urs; ... (2023). The impact of competing stroke etiologies in patients with atrial fibrillation. (In Press). European stroke journal, p. 23969873231185220. Sage 10.1177/23969873231185220
BACKGROUND Data on the impact of competing stroke etiologies in stroke patients with atrial fibrillation (AF) are scarce. METHODS We used prospectively obtained data from an observational registry (Novel-Oral-Anticoagulants-in-Ischemic-Stroke-Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efab6d12a7d998a85c0c313aa49158a0
https://boris.unibe.ch/184453/1/zietz-et-al-2023-the-impact-of-competing-stroke-etiologies-in-patients-with-atrial-fibrillation.pdf
https://boris.unibe.ch/184453/1/zietz-et-al-2023-the-impact-of-competing-stroke-etiologies-in-patients-with-atrial-fibrillation.pdf
Autor:
Traenka, Christopher, Gensicke, Henrik, Schaedelin, Sabine, Luft, Andreas, Arnold, Marcel, Michel, Patrik, Kägi, Georg, Kahles, Timo, Nolte, Christian H, Kellert, Lars, Rosenbaum, Sverre, Sztaizel, Roman, Brehm, Alex, Stippich, Christoph, Psychogios, Marios, Lyrer, Philippe, Engelter, Stefan T
Introduction The type of antithrombotic treatment in cervical artery dissection patients is still a matter of debate. Most physicians prefer anticoagulants over antiplatelet agents for stroke prevention. However, this approach is not evidence-based a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83aa520b6b31b67a4511d89061ee0b97
Autor:
Engelter ST; Neurology and Neurorehabilitation, University Department of Geriatric Medicine FELIX PLATTER, University of Basel, Basel, Switzerland., Lyrer P; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland., Traenka C; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Petersgraben 4, Basel 4031, Switzerland.
Publikováno v:
Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2021 Aug 12; Vol. 14, pp. 17562864211037238. Date of Electronic Publication: 2021 Aug 12 (Print Publication: 2021).